DekaBank Deutsche Girozentrale’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.84M | Hold |
27,611
| – | – | 0.01% | 506 |
|
|
2026
Q1 | $6.98M | Hold |
27,611
| – | – | 0.01% | 507 |
|
|
2025
Q4 | $10.8M | Hold |
27,611
| – | – | 0.02% | 444 |
|
|
2025
Q3 | $7.14M | Hold |
27,611
| – | – | 0.01% | 517 |
|
|
2025
Q2 | $6.02M | Sell |
27,611
-51
| -0.2% | -$10.9K | 0.01% | 536 |
|
|
2025
Q1 | $6.06M | Buy |
27,662
+51
| +0.2% | +$14.1K | 0.01% | 531 |
|
|
2024
Q4 | $9.08M | Hold |
27,611
| – | – | 0.02% | 474 |
|
|
2024
Q3 | $8.51M | Buy |
27,611
+258
| +0.9% | +$79K | 0.02% | 491 |
|
|
2024
Q2 | $8.96M | Sell |
27,353
-309
| -1% | -$109K | 0.02% | 470 |
|
|
2024
Q1 | $10.8M | Buy |
27,662
+4,160
| +18% | +$1.54M | 0.02% | 427 |
|
|
2023
Q4 | $8.26M | Buy |
23,502
+111
| +0.5% | +$39.3K | 0.02% | 475 |
|
|
2023
Q3 | $8.81M | Buy |
23,391
+3,020
| +15% | +$1.17M | 0.02% | 443 |
|
|
2023
Q2 | $7.67M | Buy |
20,371
+489
| +2% | +$175K | 0.02% | 475 |
|
|
2023
Q1 | $6.71M | Buy |
19,882
+121
| +0.6% | +$35.4K | 0.02% | 490 |
|
|
2022
Q4 | $4.69M | Sell |
19,761
-4,826
| -20% | -$1.14M | 0.01% | 551 |
|
|
2022
Q3 | $6.13M | Sell |
24,587
-3,616
| -13% | -$1.1M | 0.02% | 478 |
|
|
2022
Q2 | $8.34M | Buy |
28,203
+5,822
| +26% | +$1.89M | 0.02% | 422 |
|
|
2022
Q1 | $9.4M | Buy |
22,381
+1,069
| +5% | +$418K | 0.02% | 433 |
|
|
2021
Q4 | $9.92M | Buy |
21,312
+7,078
| +50% | +$3.05M | 0.02% | 419 |
|
|
2021
Q3 | $6.15M | Buy |
14,234
+936
| +7% | +$395K | 0.02% | 486 |
|
|
2021
Q2 | $4.74M | Sell |
13,298
-13,057
| -50% | -$4.31M | 0.01% | 532 |
|
|
2021
Q1 | $7.31M | Buy |
26,355
+13,021
| +98% | +$3.73M | 0.02% | 404 |
|
|
2020
Q4 | $3.71M | Buy |
13,334
+3,770
| +39% | +$1.06M | 0.01% | 524 |
|
|
2020
Q3 | $2.58M | Buy |
9,564
+756
| +9% | +$200K | 0.01% | 540 |
|
|
2020
Q2 | $1.96M | Buy |
8,808
+732
| +9% | +$144K | 0.01% | 505 |
|
|
2020
Q1 | $1.21M | Buy |
8,076
+1,991
| +33% | +$306K | 0.01% | 557 |
|
|
2019
Q4 | $913K | Buy |
+6,085
| New | +$886K | 0.01% | 710 |
|
|
2019
Q3 | – | Sell |
-13,035
| Closed | -$1.63M | – | 1134 |
|
|
2019
Q2 | $1.63M | Buy |
13,035
+7,743
| +146% | +$914K | 0.01% | 678 |
|
|
2019
Q1 | $621K | Sell |
5,292
-7,743
| -59% | -$805K | ﹤0.01% | 865 |
|
|
2018
Q4 | $1.24M | Buy |
13,035
+7,743
| +146% | +$840K | 0.01% | 627 |
|
|
2018
Q3 | $621K | Hold |
5,292
| – | – | ﹤0.01% | 886 |
|
|
2018
Q2 | $526K | Buy |
+5,292
| New | +$487K | ﹤0.01% | 895 |
|
Other funds holding WST
GIM
DekaBank Deutsche Girozentrale's WST Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its West Pharmaceutical (WST) position steady in Q2 2026 at 27,611 shares worth $6.84M. The position accounts for 0.01% of the portfolio, ranked #506.
DekaBank Deutsche Girozentrale first reported a position in WST in Q2 2018 and has held it in 32 quarters since. The position peaked at $10.8M in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- DekaBank Deutsche Girozentrale held 27,611 shares of West Pharmaceutical worth $6.84M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its West Pharmaceutical share count unchanged in Q2 2026.
- West Pharmaceutical made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #506 holding.
- DekaBank Deutsche Girozentrale first reported a position in West Pharmaceutical in Q2 2018 and has held it in 32 quarters since.
- DekaBank Deutsche Girozentrale's West Pharmaceutical position peaked at $10.8M in Q4 2025.
- 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.